• About
  • Innovators
  • Corporates
  • Case Studies
  • Content Hub
Leading Edge Only Leading Edge Only
  • Login
  • Join
About
Innovators
Corporates
Case Studies
Content Hub

John Puziss

Yale University, Director

This user is yet to add a description about themselves

User Verified
Register for free to view their full profile
Get Started

Connection Limit

You’ve reached your connections limit

Resets on {{ date }}

Contact us
  • Innovations
Published
Environment & Sustainability

Washwater Treatment Technique

A novel washwater treatment technique that has the potential to significantly reduce cost of controlling emissions from amine based carbon capture facilities.

By John Puziss

Reference Number   01428

Last Update   Nov 15, 2021

Published
Power & Utilities

Supercritical MeOH Extraction

By combining extraction and conversion in a single step, this process uses 70% less energy than the previous methods; A single procedure can be used to yield high-value byproducts.

By John Puziss

Reference Number   01432

Last Update   Nov 15, 2021

Published
Telecommunications

Distributed Motion Sensors

Functions as a visual human filter that robustly determines the presence of humans, translates pixels into tracking information and recognizes gestures such as sitting down etc.

By John Puziss

Reference Number   01436

Last Update   Nov 15, 2021

Published
Telecommunications

Sparse Superposition Codes

The first coding method to have the communication rate close to channel capacity at all scales of code size, and the error probability exponentially small.

By John Puziss

Reference Number   01439

Last Update   Nov 15, 2021

Published
Medical

Vaccine for Leptospirosis

It protects against a lethal challenge with various live Leptospira species; OCR6320 is a safe and efficacious novel vaccine candidate for the treatment of Leptospira infections.

By John Puziss

Reference Number   01445

Last Update   Nov 15, 2021

Published
Medical

Drug Candidate for Oncology

It results in potent inhibition of angiogenesis and tumorigenesis and it causes a marked decrease in tumour volume in a mouse xenograft model.

By John Puziss

Reference Number   01448

Last Update   Nov 15, 2021

Leading Edge Only
© 2025 Leading Edge Only LTD
  • About
  • About
  • Corporates
  • Innovators
  • Members
  • Partners
  • Help
  • Contact Us
  • Help Center / FAQs
  • Terms and Conditions
  • Privacy Policy
  • Cookie Policy
  • Acceptable Use Policy
  • Supported Browsers
  • Functions
  • Add your Innovation
  • Create your Challenge
  • Search Innovations
  • Explore
  • Challenges
  • Collaborators
  • Innovations
  • Members
  • Universities
  • Content Hub
  • Case Studies
  • Resources
  • Terms and Conditions
  • Privacy Policy
  • Cookie Policy
© 2025 Leading Edge Only LTD

Your experience on this site will be improved by allowing cookies.